ZOLGENSMA Trademark

Trademark Overview


On Monday, February 1, 2021, a trademark application was filed for ZOLGENSMA with the United States Patent and Trademark Office. The USPTO has given the ZOLGENSMA trademark a serial number of 90501485. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 30, 2024. This trademark is owned by Novartis AG. The ZOLGENSMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression
zolgensma

General Information


Serial Number90501485
Word MarkZOLGENSMA
Filing DateMonday, February 1, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 29, 2021

Trademark Statements


Description of MarkThe mark consists of a small section of a DNA helix above and to the left of the letter "Z" in the word "ZOLGENSMA", which is in lowercase; "ZOLGEN" and the left side and middle bars of the helix are dark magenta and "SMA" and the right side of the helix are green.
Goods and ServicesPharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression
Indication of Colors claimedThe color(s) dark magenta and green is/are claimed as a feature of the mark.
Translation of Words in MarkThe wording "ZOLGENSMA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 4, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4002
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4002
CH

Trademark Events


Event DateEvent Description
Tuesday, May 25, 2021ASSIGNED TO EXAMINER
Thursday, February 4, 2021NEW APPLICATION ENTERED
Tuesday, May 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 5, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, May 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 29, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 29, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 9, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 24, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 24, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 22, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 22, 2022SOU EXTENSION 1 FILED
Tuesday, February 22, 2022SOU EXTENSION 1 GRANTED
Wednesday, August 24, 2022SOU EXTENSION 2 FILED
Wednesday, August 24, 2022SOU EXTENSION 2 GRANTED
Friday, August 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 21, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 21, 2023SOU EXTENSION 3 FILED
Tuesday, February 21, 2023SOU EXTENSION 3 GRANTED
Tuesday, February 20, 2024SOU EXTENSION 5 GRANTED
Tuesday, February 20, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 20, 2024SOU EXTENSION 5 FILED
Wednesday, February 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 30, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 30, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, August 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 5, 2023SOU TEAS EXTENSION RECEIVED
Saturday, August 5, 2023SOU EXTENSION 4 FILED
Saturday, August 5, 2023SOU EXTENSION 4 GRANTED